NL194166B - Naftoxazinen en bereiding en toepassing daarvan. Hexahydronaft[2,3-b]-1,4-oxazinen en farmaceutische preparaten die ze bevatten. - Google Patents

Naftoxazinen en bereiding en toepassing daarvan. Hexahydronaft[2,3-b]-1,4-oxazinen en farmaceutische preparaten die ze bevatten.

Info

Publication number
NL194166B
NL194166B NL8501526A NL8501526A NL194166B NL 194166 B NL194166 B NL 194166B NL 8501526 A NL8501526 A NL 8501526A NL 8501526 A NL8501526 A NL 8501526A NL 194166 B NL194166 B NL 194166B
Authority
NL
Netherlands
Prior art keywords
hexahydronaft
naphthoxazines
oxazines
preparation
application
Prior art date
Application number
NL8501526A
Other languages
English (en)
Other versions
NL194166C (nl
NL8501526A (nl
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NL8501526A publication Critical patent/NL8501526A/nl
Publication of NL194166B publication Critical patent/NL194166B/nl
Application granted granted Critical
Publication of NL194166C publication Critical patent/NL194166C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00—Compounds containing azido groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NL8501526A 1984-06-12 1985-05-29 Naftoxazinen en bereiding en toepassing daarvan. Hexahydronaft[2,3-b]-1,4-oxazinen en farmaceutische preparaten die ze bevatten. NL194166C (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3421729 1984-06-12
DE3421729 1984-06-12
DE3508263 1985-03-08
DE3508263 1985-03-08

Publications (3)

Publication Number Publication Date
NL8501526A NL8501526A (nl) 1986-01-02
NL194166B true NL194166B (nl) 2001-04-02
NL194166C NL194166C (nl) 2001-08-03

Family

ID=25822036

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8501526A NL194166C (nl) 1984-06-12 1985-05-29 Naftoxazinen en bereiding en toepassing daarvan. Hexahydronaft[2,3-b]-1,4-oxazinen en farmaceutische preparaten die ze bevatten.

Country Status (28)

Country Link
US (1) US4656167A (nl)
JP (1) JPS611676A (nl)
AT (1) AT394717B (nl)
AU (1) AU582751B2 (nl)
BE (1) BE902600A (nl)
CA (1) CA1285561C (nl)
CH (1) CH666031A5 (nl)
CY (1) CY1581A (nl)
DE (1) DE3520104C2 (nl)
DK (1) DK172306B1 (nl)
ES (1) ES8704469A1 (nl)
FI (1) FI86301C (nl)
FR (1) FR2565586B1 (nl)
GB (1) GB2160200B (nl)
GR (1) GR851418B (nl)
HK (1) HK11891A (nl)
HU (1) HU193979B (nl)
IE (1) IE58398B1 (nl)
IL (1) IL75468A (nl)
IT (1) IT1200079B (nl)
LU (1) LU85941A1 (nl)
MY (1) MY102059A (nl)
NL (1) NL194166C (nl)
NZ (1) NZ212358A (nl)
PH (1) PH23666A (nl)
PT (1) PT80634B (nl)
SE (1) SE465428B (nl)
SG (1) SG9691G (nl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8616669D0 (en) * 1986-07-09 1986-08-13 Merk Sharpe & Dohme Ltd Pharmaceutical compositions
US5071875A (en) * 1989-09-25 1991-12-10 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
HU214591B (hu) * 1989-12-14 1998-04-28 Novartis Ag. Eljárás egy naftoxazinszármazék malonátsójának és az ilyen hatóanyagot tartalmazó gyógyszerkészítmények előállítására
DE4329776A1 (de) * 1993-09-03 1995-03-09 Sandoz Ag Naphthoxazine, ihre Herstellung und Verwendung
TW357143B (en) * 1995-07-07 1999-05-01 Novartis Ag Benzo[g]quinoline derivatives
CN102131790A (zh) * 2008-06-27 2011-07-20 H.隆德贝克有限公司 新型苯酚型和儿茶酚型胺及其前药

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2194421B1 (nl) * 1972-08-03 1975-10-17 Cerpha
AU521527B2 (en) * 1979-09-12 1982-04-08 Dow Chemical Company, The Dehydrohalogenation of (polyhaloalkyl) benzenes
US4368201A (en) * 1981-07-20 1983-01-11 Usv Pharmaceutical Corporation Tetrahydronaphthoxazoles
US4420480A (en) * 1981-11-20 1983-12-13 Merck & Co., Inc. Hexahydronaphth[1,2-b]-1,4-oxazines
CA1204745A (en) * 1981-11-20 1986-05-20 Merck Co. Hexahydronaphth (1,2-b) -1,4 -oxazines
DE4003262A1 (de) * 1990-02-03 1991-08-08 Sandoz Ag Neues naphthoxazin, seine herstellung und verwendung

Also Published As

Publication number Publication date
GB2160200B (en) 1988-03-16
AU4345885A (en) 1985-12-19
CA1285561C (en) 1991-07-02
GB8514636D0 (en) 1985-07-10
FI852325A0 (fi) 1985-06-11
DK259185D0 (da) 1985-06-10
HUT39438A (en) 1986-09-29
IT8548195A0 (it) 1985-06-11
ES544074A0 (es) 1987-04-01
IT1200079B (it) 1989-01-05
US4656167A (en) 1987-04-07
PH23666A (en) 1989-09-27
HK11891A (en) 1991-02-22
ES8704469A1 (es) 1987-04-01
PT80634A (en) 1985-07-01
LU85941A1 (fr) 1986-01-24
NL194166C (nl) 2001-08-03
HU193979B (en) 1987-12-28
NL8501526A (nl) 1986-01-02
IE851437L (en) 1985-12-12
SG9691G (en) 1991-04-05
AU582751B2 (en) 1989-04-13
SE465428B (sv) 1991-09-09
GR851418B (nl) 1985-11-25
DE3520104A1 (de) 1985-12-12
DE3520104C2 (de) 1997-01-23
MY102059A (en) 1992-03-31
DK172306B1 (da) 1998-03-09
BE902600A (fr) 1985-12-06
CY1581A (en) 1992-04-03
ATA172385A (de) 1991-11-15
SE8502865D0 (sv) 1985-06-10
CH666031A5 (de) 1988-06-30
IL75468A0 (en) 1985-10-31
JPS611676A (ja) 1986-01-07
FI86301B (fi) 1992-04-30
PT80634B (pt) 1987-10-20
IL75468A (en) 1989-05-15
FI852325L (fi) 1985-12-13
JPH0576472B2 (nl) 1993-10-22
FR2565586A1 (fr) 1985-12-13
GB2160200A (en) 1985-12-18
FR2565586B1 (fr) 1989-09-15
IE58398B1 (en) 1993-09-08
DK259185A (da) 1985-12-13
AT394717B (de) 1992-06-10
SE8502865L (sv) 1985-12-13
NZ212358A (en) 1989-01-27
FI86301C (fi) 1992-08-10

Similar Documents

Publication Publication Date Title
NL300045I2 (nl) Fluorcytidine-derivaten, de bereiding daarvan en geneesmiddelen die deze derivaten bevatten.
NL192878B (nl) Aromatische heterocyclische verbindingen en farmaceutische en cosmetische preparaten die deze bevatten.
NL193420B (nl) Antibiotische verbindingen, preparaten die deze bevatten en gebruik ervan.
NL930061I2 (nl) Anti-fungus-middelen, werkwijze ter bereiding daarvan en farmaceutische preparaten, die deze anti-fungus-middelen bevatten.
DE3780223D1 (de) Arzneimittel mit gesteuerter freisetzung.
NL194239B (nl) Dialkoxyfosfinolmethylbenzamideverbindingen en farmaceutische preparaten, die deze bevatten.
NL950030I2 (nl) Dialkoxypyridinen, werkwijzen ter bereiding daarvan, toepassing daarvan en geneesmiddelen die ze bevatten.
DE3587577D1 (de) Antimykotische pharmazeutische Präparate.
IT1213379B (it) Tiazolo [4,5-c]chinoline, procedimento per la loro preparazione e composizioni farmaceutiche che le contengono.
NO854194L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende antracyklinglykosider.
NL195028B (nl) Cyclosporinebevattend farmaceutisch preparaat.
DE3580304D1 (de) Arzneimittel.
NL192721B (nl) Benzonorborneenderivaten, werkwijzen voor het bereiden ervan alsmede geneeskundige en cosmetische preparaten, die dergelijke derivaten bevatten.
NO873534L (no) Stabilt farmasoeytisk gelpreparat.
IT8721411A0 (it) Composizione farmaceutica idrosolubile contenente n acetilsisteina.
NL193819B (nl) Naftaleenderivaten alsmede farmaceutische en cosmetische preparaten, die deze derivaten bevatten.
DE3262516D1 (en) Omega-cyano-1, omega-diphenyl azalcane derivatives, their preparation and pharmaceutical preparations containing them
NL8601838A (nl) Distamycinederivaten, werkwijze voor de bereiding ervan, alsmede farmaceutische preparaten, die deze derivaten bevatten.
IT8721410A0 (it) Composizione farmaceutica idrosolubile contenente n acetilcisteina.
IL84765A0 (en) Pyridazodiazepine derivatives,their manufacture and pharmaceutical compositions containing them
IL81874A0 (en) Substituted thiazoles and oxazoles,their preparation and pharmaceutical compositions containing them
DE3168951D1 (en) Tetra-substituted benzene derivatives, their preparation and pharmaceutical preparations containing them
NO862439L (no) Farmasoeytiske preparater.
NL194431B (nl) Farmaceutische preparaten die ranitidine bevatten.
NL193541B (nl) 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: NOVARTIS AG

BK Erratum

Free format text: PAT. BUL. 10/2001, HEADING P, SECTION 2, PAGE 1179, PATENT NUMBER 194166; THE TITLE OF THE INVENTION SHOULD READ: HEXAHYDRONAFT/(2,3-B/)-1,4-OXAZINEN EN FARMACEUTISCHE PREPARATEN DIE ZE BEVATTEN.

V1 Lapsed because of non-payment of the annual fee

Effective date: 20031201